NMF-SVM based CAD tool applied to functional brain images for the diagnosis of Alzheimer's disease

The Evolution of Artificial Intelligence in Nuclear Medicine

Nuclear medicine has continuously evolved since its beginnings, constantly improving the diagnosis and treatment of various diseases. The integration of artificial intelligence (AI) is one of the latest revolutionizing chapters, promising significant advancements in diagnosis, prognosis, segmentation, image quality enhancement, and theranostics. Early AI applications in nuclear medicine focused on improving diagnostic accuracy, leveraging machine learning algorithms for disease classification and outcome prediction. Advances in deep learning, including convolutional and more recently transformer-based neural networks, have further enabled more precise diagnosis and image segmentation as well as low-dose imaging, and patient-specific dosimetry for personalized treatment. Generative AI, driven by large language models and diffusion techniques, is now allowing the process, interpretation, and generation of complex medical language and images. Despite these achievements, challenges such as data scarcity, heterogeneity, and ethical concerns remain barriers to clinical translation. Addressing these issues through interdisciplinary collaboration will pave the way for a broader adoption of AI in nuclear medicine, potentially enhancing patient care and optimizing diagnosis and therapeutic outcomes.

Diagnosis of Alzheimer's disease using hypergraph p-Laplacian regularized multi-task feature learning

Multimodal data-based classification methods have been widely used in the diagnosis of Alzheimer's disease (AD) and have achieved better performance than single-modal-based methods. However, most classification methods based on multimodal data tend to consider only the correlation between different modal data and ignore the inherent non-linear higher-order relationships between similar data, which can improve the robustness of the model. Therefore, this study proposes a hypergraph p-Laplacian regularized multi-task feature selection (HpMTFS) method for AD classification. Specifically, feature selection for each modal data is considered as a distinct task and the common features of multimodal data are extracted jointly by group-sparsity regularizer. In particular, two regularization terms are introduced in this study, namely (1) a hypergraph p-Laplacian regularization term to retain higher-order structural information for similar data, and (2) a Frobenius norm regularization term to improve the noise immunity of the model. Finally, using a multi-kernel support vector machine to fuse multimodal features and perform the final classification. We used baseline sMRI, FDG-PET, and AV-45 PET imaging data from 528 subjects in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to evaluate our approach. Experimental results show that our HpMTFS method outperforms existing multimodal-based classification methods.

Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging

OBJECTIVES

This article aimed to carry out a narrative literature review of early diagnostic markers of Alzheimer's disease (AD) based on both micro and macro levels of pathology, indicating the shortcomings of current biomarkers and proposing a novel biomarker of structural integrity that associates the hippocampus and adjacent ventricle together. This could help to reduce the influence of individual variety and improve the accuracy and validity of structural biomarker.

METHODS

This review was based on presenting comprehensive background of early diagnostic markers of AD. We have compiled those markers into micro level and macro level, and discussed the advantages and disadvantages of them. Eventually the ratio of gray matter volume to ventricle volume was put forward.

RESULTS

The costly methodologies and related high patient burden of "micro" biomarkers (cerebrospinal fluid biomarkers) hinder the implementation in routine clinical examination. In terms of "macro" biomarkers- hippocampal volume (HV), there is a large variation of it among population, which undermines its validity Considering the gray matter atrophies while the adjacent ventricular volume enlarges, we assume the hippocampal to ventricle ratio (HVR) is a more reliable marker than HV alone the emerging evidence showed hippocampal to ventricle ratio predicts memory functions better than HV alone in elderly sample.

CONCLUSIONS

The ratio between gray matter structures and adjacent ventricular volumes counts as a promising superior diagnostic marker of early neurodegeneration.

Ensemble Model for Diagnostic Classification of Alzheimer's Disease Based on Brain Anatomical Magnetic Resonance Imaging

Alzheimer's is one of the fast-growing diseases among people worldwide leading to brain atrophy. Neuroimaging reveals extensive information about the brain's anatomy and enables the identification of diagnostic features. Artificial intelligence (AI) in neuroimaging has the potential to significantly enhance the treatment process for Alzheimer's disease (AD). The objective of this study is two-fold: (1) to compare existing Machine Learning (ML) algorithms for the classification of AD. (2) To propose an effective ensemble-based model for the same and to perform its comparative analysis. In this study, data from the Alzheimer's Diseases Neuroimaging Initiative (ADNI), an online repository, is utilized for experimentation consisting of 2125 neuroimages of Alzheimer's disease (n = 975), mild cognitive impairment (n = 538) and cognitive normal (n = 612). For classification, the framework incorporates a Decision Tree (DT), Random Forest (RF), Naïve Bayes (NB), and K-Nearest Neighbor (K-NN) followed by some variations of Support Vector Machine (SVM), such as SVM (RBF kernel), SVM (Polynomial Kernel), and SVM (Sigmoid kernel), as well as Gradient Boost (GB), Extreme Gradient Boosting (XGB) and Multi-layer Perceptron Neural Network (MLP-NN). Afterwards, an Ensemble Based Generic Kernel is presented where Master-Slave architecture is combined to attain better performance. The proposed model is an ensemble of Extreme Gradient Boosting, Decision Tree and SVM_Polynomial kernel (XGB + DT + SVM). At last, the proposed method is evaluated using cross-validation using statistical techniques along with other ML models. The presented ensemble model (XGB + DT + SVM) outperformed existing state-of-the-art algorithms with an accuracy of 89.77%. The efficiency of all the models was optimized using Grid-based tuning, and the results obtained after such process showed significant improvement. XGB + DT + SVM with optimized parameters outperformed all other models with an efficiency of 95.75%. The implication of the proposed ensemble-based learning approach clearly shows the best results compared to other ML models. This experimental comparative analysis improved understanding of the above-defined methods and enhanced their scope and significance in the early detection of Alzheimer's disease.

Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers

Purpose: We evaluate the ability of Artificial Intelligence with automatic classification methods applied to semi-quantitative data from brain ¹⁸F-FDG PET/CT to improve the differential diagnosis between Alzheimer Disease (AD) and Mild Cognitive Impairment (MCI). Procedures: We retrospectively analyzed a total of 150 consecutive patients who underwent diagnostic evaluation for suspected AD (n = 67) or MCI (n = 83). All patients received brain 18F-FDG PET/CT according to the international guidelines, and images were analyzed both Qualitatively (QL) and Quantitatively (QN), the latter by a fully automated post-processing software that produced a z score metabolic map of 25 anatomically different cortical regions. A subset of n = 122 cases with a confirmed diagnosis of AD (n = 53) or MDI (n = 69) by 18–24-month clinical follow-up was finally included in the study. Univariate analysis and three automated classification models (classification tree –ClT-, ridge classifier –RC- and linear Support Vector Machine –lSVM-) were considered to estimate the ability of the z scores to discriminate between AD and MCI cases in. Results: The univariate analysis returned 14 areas where the z scores were significantly different between AD and MCI groups, and the classification accuracy ranged between 74.59% and 76.23%, with ClT and RC providing the best results. The best classification strategy consisted of one single split with a cut-off value of ≈ −2.0 on the z score from temporal lateral left area: cases below this threshold were classified as AD and those above the threshold as MCI. Conclusions: Our findings confirm the usefulness of brain 18F-FDG PET/CT QL and QN analyses in differentiating AD from MCI. Moreover, the combined use of automated classifications models can improve the diagnostic process since its use allows identification of a specific hypometabolic area involved in AD cases in respect to MCI. This data improves the traditional 18F-FDG PET/CT image interpretation and the diagnostic assessment of cognitive disorders.

Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease

OBJECTIVE

Alzheimer's disease (AD) is a degenerative brain disorder, one of the main causes of death in elderly people, so early diagnosis of AD is vital to prompt access to medication and medical care. Fluorodeoxyglucose positron emission tomography (FDG-PET) proves to be effective to help understand neurological changes via measuring glucose uptake. Our aim is to explore information-rich regions of FDG-PET imaging, which enhance the accuracy and interpretability of AD-related diagnosis.

APPROACH

We develop a novel method for early diagnosis of AD based on multi-scale discriminative regions in FDG-PET imaging, which considers the diagnosis interpretability. Specifically, a multi-scale region localization (MSRL) module is discussed to automatically identify disease-related discriminative regions in full-volume FDG-PET images in an unsupervised manner, upon which a confidence score is designed to evaluate the prioritization of regions according to the density distribution of anomalies. Then, the proposed multi-scale region classification (MSRC) module adaptively fuses multi-scale region representations and makes decision fusion, which not only reduces useless information but also offers complementary information. Most of previous methods concentrate on discriminating AD from cognitively normal (CN), while mild cognitive impairment (MCI), a transitional state, facilitates early diagnosis. Therefore, our method is further applied to multiple AD-related diagnosis tasks, not limited to AD vs. CN.

MAIN RESULTS

Experimental results on the ADNI dataset show that the proposed method achieves superior performance over state-of-the-art FDG-PET-based approaches. Besides, some cerebral cortices highlighted by extracted regions cohere with medical research, further demonstrating the superiority.

SIGNIFICANCE

This work offers an effective method to achieve AD diagnosis and detect disease-affected regions in FDG-PET imaging. Our results could be beneficial for providing an additional opinion on the clinical diagnosis.

Supervised Computer-Aided Diagnosis (CAD) Methods for Classifying Alzheimer's Disease-Based Neurodegenerative Disorders

Alzheimer's disease is incurable at the moment. If it can be appropriately diagnosed, the correct treatment can postpone the patient's illness. To aid in the diagnosis of Alzheimer's disease and to minimize the time and expense associated with manual diagnosis, a machine learning technique is employed, and a transfer learning method based on 3D MRI data is proposed. Machine learning algorithms can dramatically reduce the time and effort required for human treatment of Alzheimer's disease. This approach extracts bottleneck features from the M-Net migration network and then adds a top layer to supervised training to further decrease the dimensionality and delete portions. As a consequence, the transfer network presented in this study has several advantages in terms of computational efficiency and training time savings when used as a machine learning approach for AD-assisted diagnosis. Finally, the properties of all subject slices are combined and trained in the classification layer, completing the categorization of Alzheimer's disease symptoms and standard control. The results show that this strategy has a 1.5 percentage point better classification accuracy than the one that relies exclusively on VGG16 to extract bottleneck features. This strategy could cut the time it takes for the network to learn and improve its ability to classify things. The experiment shows that the method works by using data from OASIS. A typical transfer learning network's classification accuracy is about 8% better with this method than with a typical network, and it takes about 1/60 of the time with this method.

Extracting ROI-Based Contourlet Subband Energy Feature From the sMRI Image for Alzheimer's Disease Classification

Structural magnetic resonance imaging (sMRI)-based Alzheimer's disease (AD) classification and its prodromal stage-mild cognitive impairment (MCI) classification have attracted many attentions and been widely investigated in recent years. Owing to the high dimensionality, representation of the sMRI image becomes a difficult issue in AD classification. Furthermore, regions of interest (ROI) reflected in the sMRI image are not characterized properly by spatial analysis techniques, which has been a main cause of weakening the discriminating ability of the extracted spatial feature. In this study, we propose a ROI-based contourlet subband energy (ROICSE) feature to represent the sMRI image in the frequency domain for AD classification. Specifically, a preprocessed sMRI image is first segmented into 90 ROIs by a constructed brain mask. Instead of extracting features from the 90 ROIs in the spatial domain, the contourlet transform is performed on each of these ROIs to obtain their energy subbands. And then for an ROI, a subband energy (SE) feature vector is constructed to capture its energy distribution and contour information. Afterwards, SE feature vectors of the 90 ROIs are concatenated to form a ROICSE feature of the sMRI image. Finally, support vector machine (SVM) classifier is used to classify 880 subjects from ADNI and OASIS databases. Experimental results show that the ROICSE approach outperforms six other state-of-the-art methods, demonstrating that energy and contour information of the ROI are important to capture differences between the sMRI images of AD and HC subjects. Meanwhile, brain regions related to AD can also be found using the ROICSE feature, indicating that the ROICSE feature can be a promising assistant imaging marker for the AD diagnosis via the sMRI image. Code and Sample IDs of this paper can be downloaded at https://github.com/NWPU-903PR/ROICSE.git.

Deep learning based pipelines for Alzheimer's disease diagnosis: A comparative study and a novel deep-ensemble method

BACKGROUND

Alzheimer's disease is a chronic neurodegenerative disease that destroys brain cells, causing irreversible degeneration of cognitive functions and dementia. Its causes are not yet fully understood, and there is no curative treatment. However, neuroimaging tools currently offer help in clinical diagnosis, and, recently, deep learning methods have rapidly become a key methodology applied to these tools. The reason is that they require little or no image preprocessing and can automatically infer an optimal representation of the data from raw images without requiring prior feature selection, resulting in a more objective and less biased process. However, training a reliable model is challenging due to the significant differences in brain image types.

METHODS

We aim to contribute to the research and study of Alzheimer's disease through computer-aided diagnosis (CAD) by comparing different deep learning models. In this work, there are three main objectives: i) to present a fully automated deep-ensemble approach for dementia-level classification from brain images, ii) to compare different deep learning architectures to obtain the most suitable one for the task, and (iii) evaluate the robustness of the proposed strategy in a deep learning framework to detect Alzheimer's disease and recognise different levels of dementia. The proposed approach is specifically designed to be potential support for clinical care based on patients' brain images.

RESULTS

Our strategy was developed and tested on three MRI and one fMRI public datasets with heterogeneous characteristics. By performing a comprehensive analysis of binary classification (Alzheimer's disease status or not) and multiclass classification (recognising different levels of dementia), the proposed approach can exceed state of the art in both tasks, reaching an accuracy of 98.51% in the binary case, and 98.67% in the multiclass case averaged over the four different data sets.

CONCLUSION

We strongly believe that integrating the proposed deep-ensemble approach will result in robust and reliable CAD systems, considering the numerous cross-dataset experiments performed. Being tested on MRIs and fMRIs, our strategy can be easily extended to other imaging techniques. In conclusion, we found that our deep-ensemble strategy could be efficiently applied for this task with a considerable potential benefit for patient management.

Regression and Classification of Alzheimers Disease Diagnosis using NMF-TDNet Features from 3D Brain MR Image

With the development of deep learning and medical imaging technology, many researchers use convolutional neural network(CNN) to obtain deep-level features of medical image in order to better classify Alzheimer's disease (AD) and predict clinical scores. The principal component analysis network (PCANet) is a lightweight deep-learning network that mainly uses principal component analysis (PCA) to generate multilevel filter banks for the centralized learning of samples and then performs binarization and generates blockwise histograms to obtain image features. However, the dimensions of the extracted PCANet features reaching tens of thousands or even hundreds of thousands, and the formation of the multilevel filter banks is sample data dependent, reducing the flexibility of PCANet. In this paper, based on the idea of PCANet, we propose a data-independent network called the nonnegative matrix factorization tensor decomposition network (NMF-TDNet), which improves the computational efficiency and solves the data dependence problem of PCANet. In this network, we use nonnegative matrix factorization (NMF) instead of PCA to create multilevel filter banks for sample learning, then uses the learning results to build a higher-order tensor and perform tensor decomposition (TD) to achieve data dimensionality reduction, producing the final image features. Finally, our method use these features as the input of the support vector machine (SVM) for AD classification diagnosis and clinical score prediction. The performance of our method is extensively evaluated on the ADNI-1, ADNI-2 and OASIS datasets. The experimental results show that NMF-TDNet can achieve data dimensionality reduction (the dimensionality of the extracted features numbers only a few hundred dimensions, far less than the hundreds of thousands required by PCANet) and the NMF-TDNet features as input achieved superior performance than using PCANet features as input.

Deep Learning for COVID-19 Diagnosis from CT Images

COVID-19, an infectious coronavirus disease, caused a pandemic with countless deaths. From the outset, clinical institutes have explored computed tomography as an effective and complementary screening tool alongside the reverse transcriptase-polymerase chain reaction. Deep learning techniques have shown promising results in similar medical tasks and, hence, may provide solutions to COVID-19 based on medical images of patients. We aim to contribute to the research in this field by: (i) Comparing different architectures on a public and extended reference dataset to find the most suitable; (ii) Proposing a patient-oriented investigation of the best performing networks; and (iii) Evaluating their robustness in a real-world scenario, represented by cross-dataset experiments. We exploited ten well-known convolutional neural networks on two public datasets. The results show that, on the reference dataset, the most suitable architecture is VGG19, which (i) Achieved 98.87% accuracy in the network comparison; (ii) Obtained 95.91% accuracy on the patient status classification, even though it misclassifies some patients that other networks classify correctly; and (iii) The cross-dataset experiments exhibit the limitations of deep learning approaches in a real-world scenario with 70.15% accuracy, which need further investigation to improve the robustness. Thus, VGG19 architecture showed promising performance in the classification of COVID-19 cases. Nonetheless, this architecture enables extensive improvements based on its modification, or even with preprocessing step in addition to it. Finally, the cross-dataset experiments exposed the critical weakness of classifying images from heterogeneous data sources, compatible with a real-world scenario.

Diagnosis of Alzheimer's Disease by Time-Dependent Power Spectrum Descriptors and Convolutional Neural Network Using EEG Signal

Using strategies that obtain biomarkers where early symptoms coincide, the early detection of Alzheimer's disease and its complications is essential. Electroencephalogram is a technology that allows thousands of neurons with equal spatial orientation of the duration of cerebral cortex electrical activity to be registered by postsynaptic potential. Therefore, in this paper, the time-dependent power spectrum descriptors are used to diagnose the electroencephalogram signal function from three groups: mild cognitive impairment, Alzheimer's disease, and healthy control test samples. The final feature used in three modes of traditional classification methods is recorded: k-nearest neighbors, support vector machine, linear discriminant analysis approaches, and documented results. Finally, for Alzheimer's disease patient classification, the convolutional neural network architecture is presented. The results are indicated using output assessment. For the convolutional neural network approach, the accurate meaning of accuracy is 82.3%. 85% of mild cognitive impairment cases are accurately detected in-depth, but 89.1% of the Alzheimer's disease and 75% of the healthy population are correctly diagnosed. The presented convolutional neural network outperforms other approaches because performance and the k-nearest neighbors' approach is the next target. The linear discriminant analysis and support vector machine were at the low area under the curve values.

A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG

In this paper, we review state-of-the-art approaches that apply signal processing (SP) and machine learning (ML) to automate the detection of Alzheimer's disease (AD) and its prodromal stages. In the first part of the document, we describe the economic and social implications of the disease, traditional diagnosis techniques, and the fundaments of automated AD detection. Then, we present electroencephalography (EEG) as an appropriate alternative for the early detection of AD, owing to its reduced cost, portability, and non-invasiveness. We also describe the main time and frequency domain EEG features that are employed in AD detection. Subsequently, we examine some of the main studies of the last decade that aim to provide an automatic detection of AD and its previous stages by means of SP and ML. In these studies, brain data was acquired using multiple medical techniques such as magnetic resonance imaging, positron emission tomography, and EEG. The main aspects of each approach, namely feature extraction, classification model, validation approach, and performance metrics, are compiled and discussed. Lastly, a set of conclusions and recommendations for future research on AD automatic detection are drawn in the final section of the paper.

Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by 18F-FDG Brain PET Imaging

Alzheimer's Disease (AD), one of the main causes of death in elderly people, is characterized by Mild Cognitive Impairment (MCI) at prodromal stage. Nevertheless, only part of MCI subjects could progress to AD. The main objective of this paper is thus to identify those who will develop a dementia of AD type among MCI patients. ¹⁸F-FluoroDeoxyGlucose Positron Emission Tomography (¹⁸F-FDG PET) serves as a neuroimaging modality for early diagnosis as it can reflect neural activity via measuring glucose uptake at resting-state. In this paper, we design a deep network on ¹⁸F-FDG PET modality to address the problem of AD identification at early MCI stage. To this end, a Multi-view Separable Pyramid Network (MiSePyNet) is proposed, in which representations are learned from axial, coronal and sagittal views of PET scans so as to offer complementary information and then combined to make a decision jointly. Different from the widely and naturally used 3D convolution operations for 3D images, the proposed architecture is deployed with separable convolution from slice-wise to spatial-wise successively, which can retain the spatial information and reduce training parameters compared to 2D and 3D networks, respectively. Experiments on ADNI dataset show that the proposed method can yield better performance than both traditional and deep learning-based algorithms for predicting the progression of Mild Cognitive Impairment, with a classification accuracy of 83.05%.

Alzheimer's diagnosis using deep learning in segmenting and classifying 3D brain MR images

BACKGROUND AND OBJECTIVES

Dementia is one of the brain diseases with serious symptoms such as memory loss, and thinking problems. According to the World Alzheimer Report 2016, in the world, there are 47 million people having dementia and it can be 131 million by 2050. There is no standard method to diagnose dementia, and consequently unable to access the treatment effectively. Hence, the computational diagnosis of the disease from brain Magnetic Resonance Image (MRI) scans plays an important role in supporting the early diagnosis. Alzheimer's Disease (AD), a common type of Dementia, includes problems related to disorientation, mood swings, not managing self-care, and behavioral issues. In this article, we present a new computational method to diagnosis Alzheimer's disease from 3D brain MR images.

METHODS

An efficient approach to diagnosis Alzheimer's disease from brain MRI scans is proposed comprising two phases: I) segmentation and II) classification, both based on deep learning. After the brain tissues are segmented by a model that combines Gaussian Mixture Model (GMM) and Convolutional Neural Network (CNN), a new model combining Extreme Gradient Boosting (XGBoost) and Support Vector Machine (SVM) is used to classify Alzheimer's disease based on the segmented tissues.

RESULTS

We present two evaluations for segmentation and classification. For comparison, the new method was evaluated using the AD-86 and AD-126 datasets leading to Dice 0.96 for segmentation in both datasets and accuracies 0.88, and 0.80 for classification, respectively.

CONCLUSION

Deep learning gives prominent results for segmentation and feature extraction in medical image processing. The combination of XGboost and SVM improves the results obtained.

Kidney segmentation from computed tomography images using deep neural network

BACKGROUND

The precise segmentation of kidneys and kidney tumors can help medical specialists to diagnose diseases and improve treatment planning, which is highly required in clinical practice. Manual segmentation of the kidneys is extremely time-consuming and prone to variability between different specialists due to their heterogeneity. Because of this hard work, computational techniques, such as deep convolutional neural networks, have become popular in kidney segmentation tasks to assist in the early diagnosis of kidney tumors. In this study, we propose an automatic method to delimit the kidneys in computed tomography (CT) images using image processing techniques and deep convolutional neural networks (CNNs) to minimize false positives.

METHODS

The proposed method has four main steps: (1) acquisition of the KiTS19 dataset, (2) scope reduction using AlexNet, (3) initial segmentation using U-Net 2D, and (4) false positive reduction using image processing to maintain the largest elements (kidneys).

RESULTS

The proposed method was evaluated in 210 CTs from the KiTS19 database and obtained the best result with an average Dice coefficient of 96.33%, an average Jaccard index of 93.02%, an average sensitivity of 97.42%, an average specificity of 99.94% and an average accuracy of 99.92%. In the KiTS19 challenge, it presented an average Dice coefficient of 93.03%.

CONCLUSION

In our method, we demonstrated that the kidney segmentation problem in CT can be solved efficiently using deep neural networks to define the scope of the problem and segment the kidneys with high precision and with the use of image processing techniques to reduce false positives.

Application of Generalized Split Linearized Bregman Iteration algorithm for Alzheimer's disease prediction

In this paper, we applied a novel method for the detection of Alzheimer's disease (AD) based on a structural magnetic resonance imaging (sMRI) dataset. Specifically, the method involved a new classification algorithm of machine learning, named Generalized Split Linearized Bregman Iteration (GSplit LBI). It combines logistic regression and structural sparsity regularizations. In the study, 57 AD patients and 47 normal controls (NCs) were enrolled. We first extracted the entire brain gray matter volume values of all subjects and then used GSplit LBI to build a predictive classification model with a 10-fold full cross-validation method. The model accuracy achieved 90.44%. To further verify which voxels in the dataset have greater impact on the prediction results, we ranked the weight parameters and obtained the top 6% of the model parameters. To verify the generalization of model prediction and the stability of feature selection, we performed a cross-test on the Alzheimer's Disease Neuroimaging Initiative (ADNI) and a Chinese dataset and achieved good performances on different cohorts. Conclusively, based on the sMRI dataset, our algorithm not only had good performance in a local cohort with high accuracy but also had good generalization of model prediction and stability of feature selection in different cohorts.

Region-of-Interest based sparse feature learning method for Alzheimer's disease identification

BACKGROUND AND OBJECTIVE

In recent years, some clinical parameters, such as the volume of gray matter (GM) and cortical thickness, have been used as anatomical features to identify Alzheimer's disease (AD) from Healthy Controls (HC) in some feature-based machine learning methods. However, fewer image-based feature parameters have been proposed, which are equivalent to these clinical parameters, to describe the atrophy of regions-of-interest (ROIs) of the brain. In this study, we aim to extract effective image-based feature parameters to improve the diagnostic performance of AD with magnetic resonance imaging (MRI) data.

METHODS

A new subspace-based sparse feature learning method is proposed, which builds a union-of-subspace representation model to realize feature extraction and disease identification. Specifically, the proposed method estimates feature dimensions reasonably, at the same time, it protects local features for the specified ROIs of the brain, and realizes image-based feature extraction and classification automatically instead of computing the volume of GM or cortical thickness preliminarily.

RESULTS

Experimental results illustrate the effectiveness and robustness of the proposed method on feature extraction and classification, which are based on the sampled clinical dataset from Peking University Third Hospital of China and the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. The extracted image-based feature parameters describe the atrophy of ROIs of the brain well as clinical parameters but show better performance in AD identification than clinical parameters. Based on them, the important ROIs for AD identification can be identified even for correlated variables.

CONCLUSION

The extracted features and the proposed identification parameters show high correlation with the volume of GM and the clinical mini-mental state examination (MMSE) score respectively. The proposed method will be useful in denoting the changes of cerebral pathology and cognitive function in AD patients.

Multiscale spatial gradient features for 18F-FDG PET image-guided diagnosis of Alzheimer's disease

BACKGROUND AND OBJECTIVE

¹⁸F-FluoroDeoxyGlucose Positron Emission Tomography (¹⁸F-FDG PET) is one of the imaging biomarkers to diagnose Alzheimer's Disease (AD). In ¹⁸F-FDG PET images, the changes of voxels' intensities reflect the differences of glucose rates, therefore voxel intensity is usually used as a feature to distinguish AD from Normal Control (NC), or at earlier stage to distinguish between progressive and stable Mild Cognitive Impairment (pMCI and sMCI). In this paper, ¹⁸F-FDG PET images are characterized in an alternative way-the spatial gradient, which is motivated by the observation that the changes of ¹⁸F-FDG rates also cause gradient changes.

METHODS

We improve Histogram of Oriented Gradient (HOG) descriptor to quantify spatial gradients, thereby achieving the goal of diagnosing AD. First, the spatial gradient of ¹⁸F-FDG PET image is computed, and then each subject is segmented into different regions by using an anatomical atlas. Second, two types of improved HOG features are extracted from each region, namely Small Scale HOG and Large Scale HOG, then some relevant regions are selected based on a classifier fed with spatial gradient features. Last, an ensemble classification framework is designed to make a decision, which considers the performance of both individual and concatenated selected regions.

RESULTS

the evaluation is done on ADNI dataset. The proposed method outperforms other state-of-the-art ¹⁸F-FDG PET-based algorithms for AD vs. NC with an accuracy, a sensitivity and a specificity values of 93.65%, 91.22% and 96.25%, respectively. For the case of pMCI vs. sMCI, the three metrics are 75.38%, 74.84% and 77.11%, which is significantly better than most existing methods. Besides, promising results are also achieved for multiple classifications under ¹⁸F-FDG PET modality.

CONCLUSIONS

¹⁸F-FDG PET images can be characterized by spatial gradient features for diagnosing AD and its early stage, and the proposed ensemble framework can enhance the classification performance.

Factor Analysis of Dynamic PET Images: Beyond Gaussian Noise

Factor analysis has proven to be a relevant tool for extracting tissue time-activity curves (TACs) in dynamic PET images, since it allows for an unsupervised analysis of the data. Reliable and interpretable results are possible only if it is considered with respect to suitable noise statistics. However, the noise in reconstructed dynamic PET images is very difficult to characterize, despite the Poissonian nature of the count rates. Rather than explicitly modeling the noise distribution, this paper proposes to study the relevance of several divergence measures to be used within a factor analysis framework. To this end, the β -divergence, widely used in other applicative domains, is considered to design the data-fitting term involved in three different factor models. The performances of the resulting algorithms are evaluated for different values of β , in a range covering Gaussian, Poissonian, and Gamma-distributed noises. The results obtained on two different types of synthetic images and one real image show the interest of applying non-standard values of β to improve the factor analysis.

An Automatic Classification Method on Chronic Venous Insufficiency Images

Chronic venous insufficiency (CVI) affect a large population, and it cannot heal without doctors' interventions. However, many patients do not get the medical advisory service in time. At the same time, the doctors also need an assistant tool to classify the patients according to the severity level of CVI. We propose an automatic classification method, named CVI-classifier to help doctors and patients. In this approach, first, low-level image features are mapped into middle-level semantic features by a concept classifier, and a multi-scale semantic model is constructed to form the image representation with rich semantics. Second, a scene classifier is trained using an optimized feature subset calculated by the high-order dependency based feature selection approach, and is used to estimate CVI's severity. At last, classification accuracy, kappa coefficient, F1-score are used to evaluate classification performance. Experiments on the CVI images from 217 patients' medical records demonstrated superior performance and efficiency for CVI-classifier, with classification accuracy up to 90.92%, kappa coefficient of 0.8735 and F1score of 0.9006. This method also outperformed doctors' diagnosis (doctors rely solely on images to make judgments) with accuracy, kappa and F1-score improved by 9.11%, 0.1250 and 0.0955 respectively.

Detection of white matter lesion regions in MRI using SLIC0 and convolutional neural network

BACKGROUND AND OBJECTIVE

White matter lesions are non-static brain lesions that have a prevalence rate up to 98% in the elderly population. Because they may be associated with several brain diseases, it is important that they are detected as soon as possible. Magnetic Resonance Imaging (MRI) provides three-dimensional data with the possibility to detect and emphasize contrast differences in soft tissues, providing rich information about the human soft tissue anatomy. However, the amount of data provided for these images is far too much for manual analysis/interpretation, representing a difficult and time-consuming task for specialists. This work presents a computational methodology capable of detecting regions of white matter lesions of the brain in MRI of FLAIR modality. The techniques highlighted in this methodology are SLIC0 clustering for candidate segmentation and convolutional neural networks for candidate classification.

METHODS

The methodology proposed here consists of four steps: (1) images acquisition, (2) images preprocessing, (3) candidates segmentation and (4) candidates classification.

RESULTS

The methodology was applied on 91 magnetic resonance images provided by DASA, and achieved an accuracy of 98.73%, specificity of 98.77% and sensitivity of 78.79% with 0.005 of false positives, without any false positives reduction technique, in detection of white matter lesion regions.

CONCLUSIONS

It is demonstrated the feasibility of the analysis of brain MRI using SLIC0 and convolutional neural network techniques to achieve success in detection of white matter lesions regions.

eDRAM: Effective early disease risk assessment with matrix factorization on a large-scale medical database: A case study on rheumatoid arthritis

Recently, a number of analytical approaches for probing medical databases have been developed to assist in disease risk assessment and to determine the association of a clinical condition with others, so that better and intelligent healthcare can be provided. The early assessment of disease risk is an emerging topic in medical informatics. If diseases are detected at an early stage, prognosis can be improved and medical resources can be used more efficiently. For example, if rheumatoid arthritis (RA) is detected at an early stage, appropriate medications can be used to prevent bone deterioration. In early disease risk assessment, finding important risk factors from large-scale medical databases and performing individual disease risk assessment have been challenging tasks. A number of recent studies have considered risk factor analysis approaches, such as association rule mining, sequential rule mining, regression, and expert advice. In this study, to improve disease risk assessment, machine learning and matrix factorization techniques were integrated to discover important and implicit risk factors. A novel framework is proposed that can effectively assess early disease risks, and RA is used as a case study. This framework comprises three main stages: data preprocessing, risk factor optimization, and early disease risk assessment. This is the first study integrating matrix factorization and machine learning for disease risk assessment that is applied to a nation-wide and longitudinal medical diagnostic database. In the experimental evaluations, a cohort established from a large-scale medical database was used that included 1007 RA-diagnosed patients and 921,192 control patients examined over a nine-year follow-up period (2000-2008). The evaluation results demonstrate that the proposed approach is more efficient and stable for disease risk assessment than state-of-the-art methods.

Unmixing dynamic PET images with variable specific binding kinetics

To analyze dynamic positron emission tomography (PET) images, various generic multivariate data analysis techniques have been considered in the literature, such as principal component analysis (PCA), independent component analysis (ICA), factor analysis and nonnegative matrix factorization (NMF). Nevertheless, these conventional approaches neglect any possible nonlinear variations in the time activity curves describing the kinetic behavior of tissues with specific binding, which limits their ability to recover a reliable, understandable and interpretable description of the data. This paper proposes an alternative analysis paradigm that accounts for spatial fluctuations in the exchange rate of the tracer between a free compartment and a specifically bound ligand compartment. The method relies on the concept of linear unmixing, usually applied on the hyperspectral domain, which combines NMF with a sum-to-one constraint that ensures an exhaustive description of the mixtures. The spatial variability of the signature corresponding to the specific binding tissue is explicitly modeled through a perturbed component. The performance of the method is assessed on both synthetic and real data and is shown to compete favorably when compared to other conventional analysis methods.

Multilevel Feature Representation of FDG-PET Brain Images for Diagnosing Alzheimer's Disease

Using a single imaging modality to diagnose Alzheimer's disease (AD) or mild cognitive impairment (MCI) is a challenging task. FluoroDeoxyGlucose Positron Emission Tomography (FDG-PET) is an important and effective modality used for that purpose. In this paper, we develop a novel method by using single modality (FDG-PET) but multilevel feature, which considers both region properties and connectivities between regions to classify AD or MCI from normal control. First, three levels of features are extracted: statistical, connectivity, and graph-based features. Then, the connectivity features are decomposed into three different sets of features according to a proposed similarity-driven ranking method, which can not only reduce the feature dimension but also increase the classifier's diversity. Last, after feeding the three levels of features to different classifiers, a new classifier selection strategy, maximum Mean squared Error (mMsE), is developed to select a pair of classifiers with high diversity. In order to do the majority voting, a decision-making scheme, a nested cross validation technique is applied to choose another classifier according to the accuracy. Experiments on Alzheimer's Disease Neuroimaging Initiative database show that the proposed method outperforms most FDG-PET-based classification algorithms, especially for classifying progressive MCI (pMCI) from stable MCI (sMCI).

Characterization of brain anatomical patterns by comparing region intensity distributions: Applications to the description of Alzheimer's disease

PURPOSE

This work presents an automatic characterization of the Alzheimer's disease describing the illness as a multidirectional departure from a baseline defining the control state, being these directions determined by a distance between functional-equivalent anatomical regions.

METHODS

After a brain parcellation, a region is described by its histogram of gray levels, and the Earth mover's distance establishes how close or far these regions are. The medoid of the control group is set as the reference and any brain is characterized by its set of distances to this medoid.

EVALUATION

This hypothesis was assessed by separating groups of patients with mild Alzheimer's disease and mild cognitive impairment from control subjects, using a subset of the Open Access Series of Imaging Studies (OASIS) database. An additional experiment evaluated the method generalization and consisted in training with the OASIS data and testing with the Minimal Interval Resonance Imaging in Alzheimer's disease (MIRIAD) database.

RESULTS

Classification between controls and patients with AD resulted in an equal error rate of 0.1 (90% of sensitivity and specificity at the same time). The automatic ranking of regions resulting is in strong agreement with those regions described as important in clinical practice. Classification with different databases results in a sensitivity of 85% and a specificity of 91%.

CONCLUSIONS

This method automatically finds out a multidimensional expression of the AD, which is directly related to the anatomical changes in specific areas such as the hippocampus, the amygdala, the planum temporale, and thalamus.

Histogram-Based Features Selection and Volume of Interest Ranking for Brain PET Image Classification

Positron emission tomography (PET) is a molecular medical imaging modality which is commonly used for neurodegenerative diseases diagnosis. Computer-aided diagnosis, based on medical image analysis, could help quantitative evaluation of brain diseases such as Alzheimer's disease (AD). A novel method of ranking the effectiveness of brain volume of interest (VOI) to separate healthy control from AD brains PET images is presented in this paper. Brain images are first mapped into anatomical VOIs using an atlas. Histogram-based features are then extracted and used to select and rank VOIs according to the area under curve (AUC) parameter, which produces a hierarchy of the ability of VOIs to separate between groups of subjects. The top-ranked VOIs are then input into a support vector machine classifier. The developed method is evaluated on a local database image and compared to the known selection feature methods. Results show that using AUC outperforms classification results in the case of a two group separation.

Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging

For effective treatment of Alzheimer's disease (AD), it is important to identify subjects who are most likely to exhibit rapid cognitive decline. We aimed to develop an automatic image interpretation system based on a deep convolutional neural network (CNN) which can accurately predict future cognitive decline in mild cognitive impairment (MCI) patients using flurodeoxyglucose and florbetapir positron emission tomography (PET). PET images of 139 patients with AD, 171 patients with MCI and 182 normal subjects obtained from Alzheimer's Disease Neuroimaging Initiative database were used. Deep CNN was trained using 3-dimensional PET volumes of AD and normal controls as inputs. Manually defined image feature extraction such as quantification using predefined region-of-interests was unnecessary for our approach. Furthermore, it used minimally processed images without spatial normalization which has been commonly used in conventional quantitative analyses. Cognitive outcome of MCI subjects was predicted using this network. The prediction accuracy of the conversion of mild cognitive impairment to AD was compared with the conventional feature-based quantification approach. Accuracy of prediction (84.2%) for conversion to AD in MCI patients outperformed conventional feature-based quantification approaches. ROC analyses revealed that performance of CNN-based approach was significantly higher than that of the conventional quantification methods (p < 0.05). Output scores of the network were strongly correlated with the longitudinal change in cognitive measurements (p < 0.05). These results show the feasibility of deep learning as a practical tool for developing predictive neuroimaging biomarker.

Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database

We evaluated the performance of amyloid PET textural and shape features in discriminating normal and Alzheimer's disease (AD) subjects, and in predicting conversion to AD in subjects with mild cognitive impairment (MCI) or significant memory concern (SMC). Subjects from the Alzheimer's Disease Neuroimaging Initiative with available baseline ¹⁸F-florbetapir and T1-MRI scans were included. The cross-sectional cohort consisted of 181 controls and 148 AD subjects. The longitudinal cohort consisted of 431 SMC/MCI subjects, 85 of whom converted to AD during follow-up. PET images were normalized to MNI space and post-processed using in-house software. Relative retention indices (SUVr) were computed with respect to pontine, cerebellar, and composite reference regions. Several textural and shape features were extracted then combined using a support vector machine (SVM) to build a predictive model of AD conversion. Diagnostic and prognostic performance was evaluated using ROC analysis and survival analysis with the Cox proportional hazard model. The three SUVr and all the tested features effectively discriminated AD subjects in cross-sectional analysis (all p < 0.001). In longitudinal analysis, the variables with the highest prognostic value were composite SUVr (AUC 0.86; accuracy 81%), skewness (0.87; 83%), local minima (0.85; 79%), Geary's index (0.86; 81%), gradient norm maximal argument (0.83; 82%), and the SVM model (0.91; 86%). The adjusted hazard ratio for AD conversion was 5.5 for the SVM model, compared with 4.0, 2.6, and 3.8 for cerebellar, pontine and composite SUVr (all p < 0.001), indicating that appropriate amyloid textural and shape features predict conversion to AD with at least as good accuracy as classical SUVr.

A Novel Early Diagnosis System for Mild Cognitive Impairment Based on Local Region Analysis: A Pilot Study

Alzheimer's disease (AD) is an irreversible neurodegenerative disorder that accounts for 60–70% of cases of dementia in the elderly. An early diagnosis of AD is usually hampered for many reasons including the variable clinical and pathological features exhibited among affected individuals. This paper presents a computer-aided diagnosis (CAD) system with the primary goal of improving the accuracy, specificity, and sensitivity of diagnosis. In this system, PiB-PET scans, which were obtained from the ADNI database, underwent five essential stages. First, the scans were standardized and de-noised. Second, an Automated Anatomical Labeling (AAL) atlas was utilized to partition the brain into 116 regions or labels that served for local (region-based) diagnosis. Third, scale-invariant Laplacian of Gaussian (LoG) was used, per brain label, to detect the discriminant features. Fourth, the regions' features were analyzed using a general linear model in the form of a two-sample t-test. Fifth, the support vector machines (SVM) and their probabilistic variant (pSVM) were constructed to provide local, followed by global diagnosis. The system was evaluated on scans of normal control (NC) vs. mild cognitive impairment (MCI) (19 NC and 65 MCI scans). The proposed system showed superior accuracy, specificity, and sensitivity as compared to other related work.

A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages

Neuroimaging has made it possible to measure pathological brain changes associated with Alzheimer's disease (AD) in vivo. Over the past decade, these measures have been increasingly integrated into imaging signatures of AD by means of classification frameworks, offering promising tools for individualized diagnosis and prognosis. We reviewed neuroimaging-based studies for AD and mild cognitive impairment classification, selected after online database searches in Google Scholar and PubMed (January, 1985-June, 2016). We categorized these studies based on the following neuroimaging modalities (and sub-categorized based on features extracted as a post-processing step from these modalities): i) structural magnetic resonance imaging [MRI] (tissue density, cortical surface, and hippocampal measurements), ii) functional MRI (functional coherence of different brain regions, and the strength of the functional connectivity), iii) diffusion tensor imaging (patterns along the white matter fibers), iv) fluorodeoxyglucose positron emission tomography (FDG-PET) (metabolic rate of cerebral glucose), and v) amyloid-PET (amyloid burden). The studies reviewed indicate that the classification frameworks formulated on the basis of these features show promise for individualized diagnosis and prediction of clinical progression. Finally, we provided a detailed account of AD classification challenges and addressed some future research directions.

Selection bias in the reported performances of AD classification pipelines

The last decade has seen a great proliferation of supervised learning pipelines for individual diagnosis and prognosis in Alzheimer's disease. As more pipelines are developed and evaluated in the search for greater performance, only those results that are relatively impressive will be selected for publication. We present an empirical study to evaluate the potential for optimistic bias in classification performance results as a result of this selection. This is achieved using a novel, resampling-based experiment design that effectively simulates the optimisation of pipeline specifications by individuals or collectives of researchers using cross validation with limited data. Our findings indicate that bias can plausibly account for an appreciable fraction (often greater than half) of the apparent performance improvement associated with the pipeline optimisation, particularly in small samples. We discuss the consistency of our findings with patterns observed in the literature and consider strategies for bias reduction and mitigation.

•

Demonstration and measurement of selection bias in AD classification experiments

•

Bias accounts for much of the performance improvement seen with pipeline optimisation.

•

Assessment of key risk factors and guidance on best research practices

•

Evidence of selection bias in results collected by a recent literature review

Computer-Aided Diagnosis System for Alzheimer's Disease Using Different Discrete Transform Techniques

The different discrete transform techniques such as discrete cosine transform (DCT), discrete sine transform (DST), discrete wavelet transform (DWT), and mel-scale frequency cepstral coefficients (MFCCs) are powerful feature extraction techniques. This article presents a proposed computer-aided diagnosis (CAD) system for extracting the most effective and significant features of Alzheimer's disease (AD) using these different discrete transform techniques and MFCC techniques. Linear support vector machine has been used as a classifier in this article. Experimental results conclude that the proposed CAD system using MFCC technique for AD recognition has a great improvement for the system performance with small number of significant extracted features, as compared with the CAD system based on DCT, DST, DWT, and the hybrid combination methods of the different transform techniques.

Use of Machine Learning to Identify Children with Autism and Their Motor Abnormalities

In the present work, we have undertaken a proof-of-concept study to determine whether a simple upper-limb movement could be useful to accurately classify low-functioning children with autism spectrum disorder (ASD) aged 2-4. To answer this question, we developed a supervised machine-learning method to correctly discriminate 15 preschool children with ASD from 15 typically developing children by means of kinematic analysis of a simple reach-to-drop task. Our method reached a maximum classification accuracy of 96.7% with seven features related to the goal-oriented part of the movement. These preliminary findings offer insight into a possible motor signature of ASD that may be potentially useful in identifying a well-defined subset of patients, reducing the clinical heterogeneity within the broad behavioral phenotype.

Exploratory graphical models of functional and structural connectivity patterns for Alzheimer's Disease diagnosis

Alzheimer's Disease (AD) is the most common neurodegenerative disease in elderly people. Its development has been shown to be closely related to changes in the brain connectivity network and in the brain activation patterns along with structural changes caused by the neurodegenerative process. Methods to infer dependence between brain regions are usually derived from the analysis of covariance between activation levels in the different areas. However, these covariance-based methods are not able to estimate conditional independence between variables to factor out the influence of other regions. Conversely, models based on the inverse covariance, or precision matrix, such as Sparse Gaussian Graphical Models allow revealing conditional independence between regions by estimating the covariance between two variables given the rest as constant. This paper uses Sparse Inverse Covariance Estimation (SICE) methods to learn undirected graphs in order to derive functional and structural connectivity patterns from Fludeoxyglucose (18F-FDG) Position Emission Tomography (PET) data and segmented Magnetic Resonance images (MRI), drawn from the ADNI database, for Control, MCI (Mild Cognitive Impairment Subjects), and AD subjects. Sparse computation fits perfectly here as brain regions usually only interact with a few other areas. The models clearly show different metabolic covariation patters between subject groups, revealing the loss of strong connections in AD and MCI subjects when compared to Controls. Similarly, the variance between GM (Gray Matter) densities of different regions reveals different structural covariation patterns between the different groups. Thus, the different connectivity patterns for controls and AD are used in this paper to select regions of interest in PET and GM images with discriminative power for early AD diagnosis. Finally, functional an structural models are combined to leverage the classification accuracy. The results obtained in this work show the usefulness of the Sparse Gaussian Graphical models to reveal functional and structural connectivity patterns. This information provided by the sparse inverse covariance matrices is not only used in an exploratory way but we also propose a method to use it in a discriminative way. Regression coefficients are used to compute reconstruction errors for the different classes that are then introduced in a SVM for classification. Classification experiments performed using 68 Controls, 70 AD, and 111 MCI images and assessed by cross-validation show the effectiveness of the proposed method.

Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles

Classification of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) from brain images using machine learning methods has become popular. Although the large majority of the existing techniques rely on a single classifier such as the Support Vector Machine (SVM), several ensemble methods such as Adaboost or Random Forests (RF) have also been explored. The ensemble methods combine the outputs of several classifiers and aim to increase performance by exploring the diversity of the base classifiers in terms of features or examples, which are usually randomly selected. In this paper we propose using a different kind of ensemble to address the three class problem of classifying AD, MCI and Control Normals (CN) from PET brain images. We propose the favourite class ensemble of classifiers where each base classifier in the ensemble uses a different feature subset which is optimized for a given class. Since different image features correspond to different sets of brain voxels, the proposed favourite class classifiers are able to take into account the fact that the spatial pattern of brain degeneration in AD changes in time as the disease progresses. We tested this approach on FDG-PET images from The Alzheimer's Disease Neuroimaging Initiative (ADNI) database using as base classifiers both Support Vector Machines (SVM) and Random Forests (RF). The ensembles systematically outperformed the corresponding single classifier with the best result (66.78%) being obtained by the SVM ensemble.

Unsupervised learning based feature extraction for differential diagnosis of neurodegenerative diseases: A case study on early-stage diagnosis of Parkinson disease

BACKGROUND

The development of MRI based methods could prove extremely valuable for identification of reliable biomarkers to aid diagnosis of neurodegenerative diseases (NDs). A great deal of current research has been aimed at identification biomarkers for both diagnosis at early stage and evaluation of the progression of NDs.

NEW METHOD

We present here a novel synergetic paradigm integrating Kohonen self organizing map (KSOM) and least squares support vector machine (LS-SVM) for individual-level clinical diagnosis of NDs. Feature are extracted in an unsupervised manner using KSOM on preprocessed brain MRIs. Thereafter, these features are fed as input to LSSVM for subject classification.

RESULTS

The applicability of the proposed methodology has been demonstrated using 831 T1-weighted MRIs obtained from Parkinson's Progression Markers Initiative (PPMI) database. We have achieved classification accuracy of up to 99% for differential diagnosis of Parkinson disease with confidence interval of 99.9%.

COMPARISON WITH OTHER EXISTING METHODS

The potential for translation of similar research findings to clinical application is greatly dependent upon two factors (1) accuracy of subject classification achieved and (2) size of the dataset used. Here, we report very high accuracy achieved on one of the largest MRI datasets using multivariate analysis tools.

CONCLUSIONS

In this paper, we describe a methodology that has the potential to be translated into first-line diagnostic tool for NDs. We also demonstrate the applicability of this methodology for diagnosing PD subjects in early stages of the disease, i.e., subjects in age of 31-60 years.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing, longitudinal, multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD). The initial study, ADNI-1, enrolled 400 subjects with early mild cognitive impairment (MCI), 200 with early AD, and 200 cognitively normal elderly controls. ADNI-1 was extended by a 2-year Grand Opportunities grant in 2009 and by a competitive renewal, ADNI-2, which enrolled an additional 550 participants and will run until 2015. This article reviews all papers published since the inception of the initiative and summarizes the results to the end of 2013. The major accomplishments of ADNI have been as follows: (1) the development of standardized methods for clinical tests, magnetic resonance imaging (MRI), positron emission tomography (PET), and cerebrospinal fluid (CSF) biomarkers in a multicenter setting; (2) elucidation of the patterns and rates of change of imaging and CSF biomarker measurements in control subjects, MCI patients, and AD patients. CSF biomarkers are largely consistent with disease trajectories predicted by β-amyloid cascade (Hardy, J Alzheimer's Dis 2006;9(Suppl 3):151-3) and tau-mediated neurodegeneration hypotheses for AD, whereas brain atrophy and hypometabolism levels show predicted patterns but exhibit differing rates of change depending on region and disease severity; (3) the assessment of alternative methods of diagnostic categorization. Currently, the best classifiers select and combine optimum features from multiple modalities, including MRI, [(18)F]-fluorodeoxyglucose-PET, amyloid PET, CSF biomarkers, and clinical tests; (4) the development of blood biomarkers for AD as potentially noninvasive and low-cost alternatives to CSF biomarkers for AD diagnosis and the assessment of α-syn as an additional biomarker; (5) the development of methods for the early detection of AD. CSF biomarkers, β-amyloid 42 and tau, as well as amyloid PET may reflect the earliest steps in AD pathology in mildly symptomatic or even nonsymptomatic subjects and are leading candidates for the detection of AD in its preclinical stages; (6) the improvement of clinical trial efficiency through the identification of subjects most likely to undergo imminent future clinical decline and the use of more sensitive outcome measures to reduce sample sizes. Multimodal methods incorporating APOE status and longitudinal MRI proved most highly predictive of future decline. Refinements of clinical tests used as outcome measures such as clinical dementia rating-sum of boxes further reduced sample sizes; (7) the pioneering of genome-wide association studies that leverage quantitative imaging and biomarker phenotypes, including longitudinal data, to confirm recently identified loci, CR1, CLU, and PICALM and to identify novel AD risk loci; (8) worldwide impact through the establishment of ADNI-like programs in Japan, Australia, Argentina, Taiwan, China, Korea, Europe, and Italy; (9) understanding the biology and pathobiology of normal aging, MCI, and AD through integration of ADNI biomarker and clinical data to stimulate research that will resolve controversies about competing hypotheses on the etiopathogenesis of AD, thereby advancing efforts to find disease-modifying drugs for AD; and (10) the establishment of infrastructure to allow sharing of all raw and processed data without embargo to interested scientific investigators throughout the world.

Sparse kernel entropy component analysis for dimensionality reduction of neuroimaging data

The neuroimaging data typically has extremely high dimensions. Therefore, dimensionality reduction is commonly used to extract discriminative features. Kernel entropy component analysis (KECA) is a newly developed data transformation method, where the key idea is to preserve the most estimated Renyi entropy of the input space data set via a kernel-based estimator. Despite its good performance, KECA still suffers from the problem of low computational efficiency for large-scale data. In this paper, we proposed a sparse KECA (SKECA) algorithm with the recursive divide-and-conquer based solution, and then applied it to perform dimensionality reduction of neuroimaging data for classification of the Alzheimer's disease (AD). We compared the SKECA with KECA, principal component analysis (PCA), kernel PCA (KPCA) and sparse KPCA. The experimental results indicate that the proposed SKECA has most superior performance to all other algorithms when extracting discriminative features from neuroimaging data for AD classification.